Skip Navigation

Biometrika 1994 81(3):527-539; doi:10.1093/biomet/81.3.527
© 1994 by Biometrika Trust
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by GRAY, R. J.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Articles

A kernel method for incorporating information on disease progression in the analysis of survival

ROBERT J. GRAY

Department of Biostatistics, Dana-Farber Cancer Institute 44 Binney Street, Boston, Massachusetts 02115, U.S.A.

Received for publication 1 June 1992. Revision received 1 July 1993.
   Abstract

This paper considers incorporating information on disease progression in the analysis of survival. A three-state model is assumed, with the distribution of each transition estimated separately. The distribution of survival following progression can depend on the time of progression. Kernel methods are used to give consistent estimators under general forms of dependence. The estimators for the individual transitions are then combined into an overall estimator of the survival distribution. A test statistic for equality of survival between treatment groups is proposed based on the tests of Pepe & Fleming (1989, 1991). In simulations the kernel method successfully incorporated dependence on the time of progression in some reasonable settings, but under extreme forms of dependence the tests had substantial bias. If survival beyond progression can be predicted fairly accurately, then gains in power over standard methods that ignore progression can be substantial, but the gains are smaller when survival beyond progression is more variable. The methodology is illustrated with an application to a breast cancer clinical trial.

Key Words: Auxiliary endpoints • Censored data • Semi-Markov model


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Stat Methods Med ResHome page
J. W Hogan and N. M Laird
Increasing efficiency from censored survival data by using random effects to model longitudinal covariates
Statistical Methods in Medical Research, February 1, 1998; 7(1): 28 - 48.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.